Prunetin 4′-<i>O</i>-Phosphate, a Novel Compound, in RAW 264.7 Macrophages Exerts Anti-Inflammatory Activity via Suppression of MAP Kinases and the NFκB Pathway

Biorenovation, a microbial enzyme-assisted degradation process of precursor compounds, is an effective approach to unraveling the potential bioactive properties of the derived compounds. In this study, we obtained a new compound, prunetin 4′-<i>O</i>-phosphate (P4P), through the biorenov...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tae-Jin Park, Hyehyun Hong, Min-Seon Kim, Jin-Soo Park, Won-Jae Chi, Seung-Young Kim
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/3b40f85073d742a59dd5a83f00c4ab12
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3b40f85073d742a59dd5a83f00c4ab12
record_format dspace
spelling oai:doaj.org-article:3b40f85073d742a59dd5a83f00c4ab122021-11-25T18:27:40ZPrunetin 4′-<i>O</i>-Phosphate, a Novel Compound, in RAW 264.7 Macrophages Exerts Anti-Inflammatory Activity via Suppression of MAP Kinases and the NFκB Pathway10.3390/molecules262268411420-3049https://doaj.org/article/3b40f85073d742a59dd5a83f00c4ab122021-11-01T00:00:00Zhttps://www.mdpi.com/1420-3049/26/22/6841https://doaj.org/toc/1420-3049Biorenovation, a microbial enzyme-assisted degradation process of precursor compounds, is an effective approach to unraveling the potential bioactive properties of the derived compounds. In this study, we obtained a new compound, prunetin 4′-<i>O</i>-phosphate (P4P), through the biorenovation of prunetin (PRN), and investigated its anti-inflammatory effects in lipopolysaccharide (LPS)-treated RAW 264.7 macrophage cells. The anti-inflammatory effect of P4P was evaluated by measuring the production of prostaglandin-E<sub>2</sub> (PGE<sub>2</sub>), nitric oxide (NO), which is an inflammation-inducing factor, and related cytokines such as tumor necrosis factor-α (TNFα), interleukin-1β (IL1β), and interleukin-6 (IL6). The findings demonstrated that P4P was non-toxic to cells, and its inhibition of the secretion of NO—as well as pro-inflammatory cytokines—was concentration-dependent. A simultaneous reduction in the protein expression level of pro-inflammatory proteins such as cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) was observed. Moreover, the phosphorylation of mitogen-activated protein kinases (MAPKs) such as extracellular signal-regulated kinases (ERKs), c-Jun <i>N</i>-terminal kinase (JNK), p38 MAPK (p38), and nuclear factor kappa B (NFκB) was downregulated. To conclude, we report that biorenovation-based phosphorylation of PRN improved its anti-inflammatory activity. Cell-based in vitro assays further confirmed that P4P could be applied in the development of anti-inflammatory therapeutics.Tae-Jin ParkHyehyun HongMin-Seon KimJin-Soo ParkWon-Jae ChiSeung-Young KimMDPI AGarticleprunetin 4′-<i>O</i>-phosphateprunetinanti-inflammatory activitiesbiorenovationphosphorylationMAPK signalingOrganic chemistryQD241-441ENMolecules, Vol 26, Iss 6841, p 6841 (2021)
institution DOAJ
collection DOAJ
language EN
topic prunetin 4′-<i>O</i>-phosphate
prunetin
anti-inflammatory activities
biorenovation
phosphorylation
MAPK signaling
Organic chemistry
QD241-441
spellingShingle prunetin 4′-<i>O</i>-phosphate
prunetin
anti-inflammatory activities
biorenovation
phosphorylation
MAPK signaling
Organic chemistry
QD241-441
Tae-Jin Park
Hyehyun Hong
Min-Seon Kim
Jin-Soo Park
Won-Jae Chi
Seung-Young Kim
Prunetin 4′-<i>O</i>-Phosphate, a Novel Compound, in RAW 264.7 Macrophages Exerts Anti-Inflammatory Activity via Suppression of MAP Kinases and the NFκB Pathway
description Biorenovation, a microbial enzyme-assisted degradation process of precursor compounds, is an effective approach to unraveling the potential bioactive properties of the derived compounds. In this study, we obtained a new compound, prunetin 4′-<i>O</i>-phosphate (P4P), through the biorenovation of prunetin (PRN), and investigated its anti-inflammatory effects in lipopolysaccharide (LPS)-treated RAW 264.7 macrophage cells. The anti-inflammatory effect of P4P was evaluated by measuring the production of prostaglandin-E<sub>2</sub> (PGE<sub>2</sub>), nitric oxide (NO), which is an inflammation-inducing factor, and related cytokines such as tumor necrosis factor-α (TNFα), interleukin-1β (IL1β), and interleukin-6 (IL6). The findings demonstrated that P4P was non-toxic to cells, and its inhibition of the secretion of NO—as well as pro-inflammatory cytokines—was concentration-dependent. A simultaneous reduction in the protein expression level of pro-inflammatory proteins such as cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) was observed. Moreover, the phosphorylation of mitogen-activated protein kinases (MAPKs) such as extracellular signal-regulated kinases (ERKs), c-Jun <i>N</i>-terminal kinase (JNK), p38 MAPK (p38), and nuclear factor kappa B (NFκB) was downregulated. To conclude, we report that biorenovation-based phosphorylation of PRN improved its anti-inflammatory activity. Cell-based in vitro assays further confirmed that P4P could be applied in the development of anti-inflammatory therapeutics.
format article
author Tae-Jin Park
Hyehyun Hong
Min-Seon Kim
Jin-Soo Park
Won-Jae Chi
Seung-Young Kim
author_facet Tae-Jin Park
Hyehyun Hong
Min-Seon Kim
Jin-Soo Park
Won-Jae Chi
Seung-Young Kim
author_sort Tae-Jin Park
title Prunetin 4′-<i>O</i>-Phosphate, a Novel Compound, in RAW 264.7 Macrophages Exerts Anti-Inflammatory Activity via Suppression of MAP Kinases and the NFκB Pathway
title_short Prunetin 4′-<i>O</i>-Phosphate, a Novel Compound, in RAW 264.7 Macrophages Exerts Anti-Inflammatory Activity via Suppression of MAP Kinases and the NFκB Pathway
title_full Prunetin 4′-<i>O</i>-Phosphate, a Novel Compound, in RAW 264.7 Macrophages Exerts Anti-Inflammatory Activity via Suppression of MAP Kinases and the NFκB Pathway
title_fullStr Prunetin 4′-<i>O</i>-Phosphate, a Novel Compound, in RAW 264.7 Macrophages Exerts Anti-Inflammatory Activity via Suppression of MAP Kinases and the NFκB Pathway
title_full_unstemmed Prunetin 4′-<i>O</i>-Phosphate, a Novel Compound, in RAW 264.7 Macrophages Exerts Anti-Inflammatory Activity via Suppression of MAP Kinases and the NFκB Pathway
title_sort prunetin 4′-<i>o</i>-phosphate, a novel compound, in raw 264.7 macrophages exerts anti-inflammatory activity via suppression of map kinases and the nfκb pathway
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/3b40f85073d742a59dd5a83f00c4ab12
work_keys_str_mv AT taejinpark prunetin4ioiphosphateanovelcompoundinraw2647macrophagesexertsantiinflammatoryactivityviasuppressionofmapkinasesandthenfkbpathway
AT hyehyunhong prunetin4ioiphosphateanovelcompoundinraw2647macrophagesexertsantiinflammatoryactivityviasuppressionofmapkinasesandthenfkbpathway
AT minseonkim prunetin4ioiphosphateanovelcompoundinraw2647macrophagesexertsantiinflammatoryactivityviasuppressionofmapkinasesandthenfkbpathway
AT jinsoopark prunetin4ioiphosphateanovelcompoundinraw2647macrophagesexertsantiinflammatoryactivityviasuppressionofmapkinasesandthenfkbpathway
AT wonjaechi prunetin4ioiphosphateanovelcompoundinraw2647macrophagesexertsantiinflammatoryactivityviasuppressionofmapkinasesandthenfkbpathway
AT seungyoungkim prunetin4ioiphosphateanovelcompoundinraw2647macrophagesexertsantiinflammatoryactivityviasuppressionofmapkinasesandthenfkbpathway
_version_ 1718411127636885504